Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Parker, Beth A ^a,b   Tschakovsky, Michael E ^c   Augeri, Amanda L ^a   Polk, Donna M ^a,b   Thompson, Paul D ^a,b   Kiernan, Francis J ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Nitric oxide; Prostaglandins; Shear stress; Vasodilation

Indexed keywords

KETOROLAC; N(G) METHYLARGININE; NITRIC OXIDE; SODIUM CHLORIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW MEDIATED DILATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIAL ARTERY; SEX DIFFERENCE; SHEAR STRESS; VASODILATATION;

ADULT; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; FEMALE; HUMANS; HYPEREMIA; INFUSIONS, INTRA-ARTERIAL; KETOROLAC; LASER-DOPPLER FLOWMETRY; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; OMEGA-N-METHYLARGININE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RADIAL ARTERY; REGIONAL BLOOD FLOW; SEX FACTORS; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 80052308390     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00400.2011     Document Type: Article

References (60)

1. Al-Qaisi M, Kharbanda RK, Mittal TK, Donald AE. Measurement of endothelial function and its clinical utility for cardiovascular risk. Vasc Health Risk Manag 4: 647-652, 2008.
2. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription (7th ed.), edited by Whaley ME, Brubaker PH, Otto RM. Philadelphia, PA: Lippincott Williams and Wilkins, 2006, p.99-102.
3. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241, 1995.
4. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 51: 203-210, 2008.
5. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 43: 645-657, 2007.
6. Cao WB, Zeng ZP, Zhu YJ, Luo WC, Cai BQ. Inhibition of nitric oxide synthesis increases the secretion of endothelin-1 in vivo and in cultured endothelial cells. Chin Med J (Engl) 107: 822-826, 1994.
7. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 42: 1037-1043, 2003.
8. Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, Abramson SB. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 165: 1582-1587, 2000.
9. Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol Heart Circ Physiol 268: H1397-H1404, 1995.
10. Dietz NM. Gender and nitric oxide-mediated vasodilation in humans. Lupus 8: 402-408, 1999.
11. Dinenno FA, Joyner MJ. Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol 287: H2576-H2584, 2004.
12. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, Goodfellow J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 101: 629-635, 2001.
13. Engelke KA, Halliwill JR, Proctor DN, Dietz NM, Joyner MJ. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 81: 1807-1814, 1996.
14. Eskurza I, Myerburgh LA, Kahn ZD, Seals DR. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J Physiol 568: 1057-1065, 2005.
15. Ferrer M, Encabo A, Conde MV, Marin J, Balfagon G. Heterogeneity of endothelium-dependent mechanisms in different rabbit arteries. J Vasc Res 32: 339-346, 1995.
16. Fischer D, Landmesser U, Spiekermann S, Hilfiker-Kleiner D, Hospely M, Muller M, Busse R, Fleming I, Drexler H. Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure. Eur J Heart Fail 9: 770-775, 2007.
17. Freitas MR, Schott C, Corriu C, Sassard J, Stoclet JC, Andriantsitohaina R. Heterogeneity of endothelium-dependent vasorelaxation in conductance and resistance arteries from Lyon normotensive and hypertensive rats. J Hypertens 21: 1505-1512, 2003.
18. Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol 102: 63-71, 2007.
19. Ghiadoni L, Versari D, Magagna A, Kardasz I, Plantinga Y, Giannarelli C, Taddei S, Salvetti A. Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 25: 361-366, 2007.
20. Gimbrone MA Jr, Alexander RW. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 189: 219-220, 1975.
21. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO and Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41: 1769-1775, 2003.
22. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57: 363-369, 2011.
23. Gryglewski RJ, mbinska-Kiec A, Korbut R. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation. Acta Biol Med Ger 37: 715-723, 1978.
24. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension 55: 1075-1085, 2010.
25. Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H, Kelm M. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46: 1276-1283, 2005.
26. Huang A, Sun D, Koller A, Kaley G. Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol Regul Integr Comp Physiol 275: R1571-R1577, 1998.
27. Ishibashi Y, Shimada T, Sakane T, Takahashi N, Sugamori T, Ohhata S, Inoue S, Katoh H, Sano K, Murakami Y, Hashimoto M. Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure. J Am Coll Cardiol 36: 1605-1611, 2000.
28. Jiang B, Seddon M, Fok H, Donald A, Chowienczyk P. Flow-mediated dilation of the radial artery is offset by flow-induced reduction in transmural pressure. Hypertension 57: 1145-50, 2011.
29. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91: 1314-1319, 1995.
30. Katz SD, Krum H. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor. Am J Cardiol 87: 1089-1092, 2001.
31. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36: 1233-1238, 2000.
32. Kooijman M, Thijssen DH, de Groot PC, Bleeker MW, van Kuppevelt HJ, Green DJ, Rongen GA, Smits P, Hopman MT. Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. J Physiol 586: 1137-1145, 2008.
33. Levenson J, Pessana F, Gariepy J, Armentano R, Simon A. Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 38: 1668-1674, 2001.
34. Li RC, Cindrova-Davies T, Skepper JN, Sellers LA. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor. Circ Res 94: 759-767, 2004.
35. Liuni A, Luca MC, Lisi M, Dragoni S, di SG, Mariani JA, Uxa A, Gori T, Parker JD. Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial function. Am J Physiol Heart Circ Physiol 299: H939-H945, 2010.
36. Maes M, Scharpe S, Cooreman W, Wauters A, Neels H, Verkerk R, De MF, D'Hondt P, Peeters D, Cosyns P. Components of biological, including seasonal, variation in hematological measurements and plasma fibrinogen concentrations in normal humans. Experientia 51: 141-149, 1995.
37. Mayahi L, Mason L, Bleasdale-Barr K, Donald A, Trender-Gerhard I, Sweeney MG, Davis MB, Wood N, Mathias CJ, Watson L, Pellerin D, Heales S, Deanfield JE, Bhatia K, Murray-Rust J, Hingorani AD. Endothelial, sympathetic, and cardiac function in inherited (6R)-L-erythro-5,6,7,8-tetrahydro-L-biopterin deficiency. Circ Cardiovasc Genet 3: 513-522, 2010.
38. Meyer MF, Lieps D, Schatz H, Pfohl M. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Microvasc Res 76: 61-65, 2008.
39. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
40. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE, MacAllister RJ. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 88: 145-151, 2001.
41. Pak KJ, Geary GG, Duckles SP, Krause DN. Male-female differences in the relative contribution of endothelial vasodilators released by rat tail artery. Life Sci 71: 1633-1642, 2002.
42. Parker BA, Smithmyer SL, Pelberg JA, Mishkin AD, Proctor DN. Sex-specific influence of aging on exercising leg blood flow. J Appl Physiol 104: 655-664, 2008.
43. Perregaux D, Chaudhuri A, Mohanty P, Bukhari L, Wilson MF, Sung BH, Dandona P. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 48: 227-232, 1999.
44. K, Green DJ, Weisbrod C, Best M, Dembo L, O'Driscoll G, Tschakovsky M. Nitric oxide is not obligatory for radial artery flowmediated dilation following release of 5 or 10 min distal occlusion. Am J Physiol Heart Circ Physiol 298: H119-H126, 2010.
45. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 568: 357-369, 2005.
46. Regensteiner JG, Popylisen S, Bauer TA, Lindenfeld J, Gill E, Smith S, Oliver-Pickett CK, Reusch JE, Weil JV. Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc Med 8: 169-175, 2003.
47. Ribeiro ML, Cella M, Farina M, Franchi A. Crosstalk between nitric oxide synthase and cyclooxygenase metabolites in the estrogenized rat uterus. Prostaglandins Leukot Essent Fatty Acids 68: 285-290, 2003.
48. Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 51: 997-1002, 2008.
49. Saunders NR, Dinenno FA, Pyke KE, Rogers AM, Tschakovsky ME. Impact of combined NO and PG blockade on rapid vasodilation in a forearm mild-to-moderate exercise transition in humans. Am J Physiol Heart Circ Physiol 288: H214-H220, 2005.
50. Schrage WG, Eisenach JH, Joyner MJ. Ageing reduces nitric-oxideand prostaglandin-mediated vasodilatation in exercising humans. J Physiol 579: 227-236, 2007.
51. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 111: 796-803, 2005.
52. Seddon M, Melikian N, Dworakowski R, Shabeeh H, Jiang B, Byrne J, Casadei B, Chowienczyk P, Shah AM. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 119: 2656-2662, 2009.
53. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, Magagna A, Virdis A, Salvetti A. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 48: 508-515, 2006.
54. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 29: 274-279, 1997.
55. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300: H2-H12, 2011.
56. Uno K, Iuchi Y, Fujii J, Sugata H, Iijima K, Kato K, Shimosegawa T, Yoshimura T. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production. J Pharmacol Exp Ther 309: 995-1002, 2004.
57. Vassalle C, Domenici C, Lubrano V, L'Abbate A. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res 40: 491-499, 2003.
58. Wray DW, Witman MA, Ives SJ, McDaniel J, Fjeldstad AS, Trinity JD, Conklin JD, Supiano MA, Richardson RS. Progressive handgrip exercise: evidence of nitric oxide-dependent vasodilation and blood flow regulation in humans. Am J Physiol Heart Circ Physiol 300: H1101-H1107, 2011.
59. Wu Y, Huang A, Sun D, Falck JR, Koller A, Kaley G. Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am J Physiol Heart Circ Physiol 280: H2456-H2461, 2001.
60. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115: 2390-2397, 2007.